Skip to main content
. 2016 Mar 25;22(6):518–524. doi: 10.1111/cns.12531

Figure 3.

Figure 3

Prognostic value of CAMKK2 in WHO grade II–IV gliomas. (A) CAMKK2 highly expressed samples showed poorer overall survival in CGGA LGG (P = 0.0126), (B) WHO grade II–IV gliomas (P = 0.0115), and in (C)TCGA GBM (WHO grade IV, P = 0.0469) samples. CAMKK2 hyper methylated samples showed better overall survival in (D) CGGA LGG (P = 0.0201), (E) WHO grade II–IV gliomas (P < 0.0001), and in (F)TCGA GBM (WHO grade IV, P = 0.0334) samples. expr, expression; methy, methylation; L, low expression or low methylation; H, high expression or high methylation.